-
My Account
My Account
As on 05 Mar, 2021 | 04:00
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 54 | 1033.35 | 1035.60 | 74 |
| 88 | 1033.20 | 1035.75 | 88 |
| 109 | 1033.00 | 1035.95 | 50 |
| 597 | 1032.80 | 1036.20 | 597 |
| 500 | 1032.70 | 1036.50 | 500 |
| 0 | Total | Total | 0 |
As on --
(OI , PRICE )
As on --
| Open | 1,048.00 |
| Previous Close | 1,048.40 |
| UC Limit | 1,153.20 |
| LC Limit | 943.60 |
| Volume | 1,716,704.00 |
| VWAP | 1,041.98 |
| Mkt Cap (Rs. Cr.) | 46,873 |
| 20D Avg Volume | 2,438,408 |
| 20D Avg Delivery | 648,679 |
| Beta | 0.310.28 |
| Face Value | 2.00 |
| TTM EPS | 25.26 |
| TTM PE | 40.90 |
| Sector PE | 39.38 |
| Book Value Per Share | 272.61 |
| P/B | 3.80 |
| Dividend Yield | 0.58 |
| P/C | 22.15 |
*Refresh in 20 seconds.
Mid range performer: Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.
indicates Weak Financials
| Revenue | -3.2% |
| NetProfit | % |
| OperatingProfit | -19.4% |
| R1 | R2 | R3 | PP | S1 | S2 | S3 | |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Lupin launches Posaconazole delayed-release tablets; share dips 2% Feb 17 2021 11:02 AM
Lupin to enter Chinese market in next one year Feb 01 2021 09:02 AM
Lupin reports Rs 438.3 crore net profit in Q3 FY21, led by improved sales in US, India Jan 29 2021 10:01 AM
Lupin Standalone December 2020 Net Sales at Rs 2,802.47 crore, up 3.19% Y-o-Y Jan 29 2021 09:01 AM
| Qty 150000 | Price 1580 | % Traded 0.03 |
| Qty 150000 | Price 1580 | % Traded 0.03 |
| Qty 300000 | Price 1674 | % Traded 0.07 |
| Qty 100000 | Price 1674 | % Traded 0.02 |
| Qty 400000 | Price 1674 | % Traded 0.09 |
| Qty 325000 | Price 1780.2 | % Traded 0.07 |
| Qty 325000 | Price 1780.2 | % Traded 0.07 |
| Qty 300000 | Price 1770 | % Traded 0.07 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 9423708 | Price 1816.67 | % Traded 2.08 |
| Qty 9423708 | Price 1816.67 | % Traded 2.08 |
| Qty 8346296 | Price 1820.43 | % Traded 1.84 |
| Qty 3266472 | Price 1832.77 | % Traded 0.72 |
| Qty 2509319 | Price 509.95 | % Traded 0.55 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Qty 2000 | Price 1041.82 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 5000 | Price 1100 | % Traded 0.00 | Post Tnx Hold. 0.03% |
| Qty 2000 | Price 1066.37 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 2347 | Price 1022.65 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 100 | Price 1060.85 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 300 | Price 1075 | % Traded 0.00 | Post Tnx Hold. 0% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 12200 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0.2% |
| Qty 1000 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
| Qty 55000 | Price 0 | % Traded 0.01 | Post Tnx Hold. 45.5% |
| Qty 95000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 45.49% |
| Qty 100000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 45.47% |
| Qty 100000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 45.45% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (%) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap | TTM PE | P/B | ROE | 1 Yr Perform | Net Profit | Net Sales | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | 1033.25 | -1.45 | 46872.50 | 40.90 | 3.79 | -2.14 | 52.72 | -403 | 15,374 | 0.34 |
| Sun Pharma | 611.20 | -1.25 | 146647.35 | 57.23 | 2.99 | 8.31 | 50.95 | 4,186 | 32,837 | 0.17 |
| Divis Labs | 3496.90 | -1.59 | 92831.71 | 49.63 | 12.70 | 18.83 | 57.25 | 1,376 | 5,394 | 0.00 |
| Dr Reddys Labs | 4492.50 | -1.80 | 74710.44 | 34.34 | 4.79 | 12.98 | 41.08 | 1,969 | 17,517 | 0.11 |
| Cipla | 805.15 | -0.20 | 64932.16 | 29.02 | 4.06 | 9.81 | 82.74 | 1,546 | 17,131 | 0.18 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>
